1 卢拱照,晏才敏,闵品醇,等.主编.儿科学及护理[M].第二版.广州:广东科技出版社,1986.94~94.

2 De Virgiliis S,Argiolu F,Sanna G,et al.Audiotory involvement in thalassemia major[J].Acta Haematol,1979,61:213.

3 Chao YH,Wu KH,Lin CY,et al.Audiologic and vestibular assessment in patients withβ-thalassemia major receiving long-term transfusion therapy.[J].Pediatr Blood Cancer,2013,60:1963.

4 林琳,孙建和,黄德亮,等.胎儿耳蜗血管纹的扫描电镜观察[J].临床耳鼻咽喉科杂志,2005,19:157.

5 Meldrum DR,Mitchell MB,Banerjee A.Cardiac preconditioning induction of endogenous tolerance to ischemia-reperfusion injury[J].Arch Surg,1993,128:1208.

6 王丽萍,王苹,杜波,等.缺氧对体外培养大鼠耳蜗毛细胞的损伤作用[J].吉林大学学报(医学版),2007,33:276.

7 Koyama S,Kaga K,Sakata H,et al.Pathological findings in the temporal bone of newborn in fants with neonatal asphyxia[J].Acta Otolaryngol,2005,125:1028.

8 王丽萍,王苹,杜波,等.缺氧对体外培养耳蜗螺旋神经节细胞及神经纤维的影响[J].临床耳鼻咽喉科杂志,2008,122:1040.

9 Borgna-Pignatti C,Galanello R.Thalassemias and related disorder[M].In:Wintrobe’s Clinical Hematology.2nded.Baltimore:Lippncott William&Wilkins,2004.1319~1365.

10 Weatherall DJ.The thalassemias[M].In:Willians Hematology.6th ed.Phiadelphia:Mc Grow Hill,2001.561~573.

11 Scheikha A,Kameswaran M,Okafor BC,et al.Otological manifestations of thalassemia intermedia:evidence of temporal bone involvement and report of a unique cholesteatoma-like lesion[J].J Laryngol Otol,1992,106:316.

12 Thio D,Prasad V,Anslow P,et al.Marrow proliferation as a cause of hearing loss in beta-thalassemia major[J].The Joural of Laryngology and Otology,2008,122:1253.

13 Onerci M,Aslan S,G¨vmr¨vk F,et al.Audiologic and impedancemetric findings within thalassemia patients[J].Int J Pediatr Otorhinolaryngol,1994,28:167.

14 黄蕾,付蓉,邵宗鸿.铁过载组织损伤特点及机制研究进展[J].中华血液学杂志,2012,33:884.

15 Britton RS,Leicester KL,Bacon BR.Iron toxicity and chelation therapy[J].Int J Hematol,2002,76:220.

16 周长华,孙建军,龚树生.活性氧族与耳蜗毛细胞凋亡[J].国际耳鼻咽喉头颈外科杂志,2009,33:321.

17 路虹,杨逸,徐鸥,等.顺铂对耳蜗螺旋神经节细胞毒性作用及机制[J].中国耳鼻咽喉头颈外科,2004,11:355.

18 陈传贵,秦巍,欧文闻,等.去铁胺对地中海贫血儿童听力的影响[J].南方医科大学学报,2008,28:1449.

19 Styles LA,Vichinsky EP.Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine[J].J Pediatr Hematol Oncol,1996,18:42.

20 Ambrosetti U,Donde E,Piatti G,et al.Audiological evalution in adult beta-thalassemia major patients under regular chelation treatment[J].Pharmacological Res,2000,42:485.

21 Piga A,Gaglioti C,Fogliaeco E,et al.Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major:a retrospective analysis[J].Haematologica,2003,88:489.

22 Kontzoglou G,Koussi A,Tsatra J,et al.Sensorineural hearing loss in children with thalassemia major in Northern Greece[J].Int J Pediatr Otorhinolaryngol,1996,35:223.

23 Kontzoglou G,Koussi A,Economou M,et al.Long term audiological evaluation of beta-thalassemic patients[J].Acta Otorhinolaryngol Belg,2004,58:113.

24 Olivieri NF,Buncic JR,Chew E,et al.Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions[J].N Engl J Med,1986,314:869.

25 Argiolu F,Diana G,Avignone A,et al.Hearing impairment during deferoxamine therapy for thalassemia major[J].J Pediatr,1991,118:826.

26 Faramarzi A,Shishegar M,Kaviani M,et al.Frequency of sensory neural hearing loss in major beta-thalassemia in southern lran[J].Iran J Pediatr,2010,20:308.

27 Chen SH,Liang DC,Lin HC,et al.Auditory and visual toxicity during deferoxamine therapy in transfusion-dependent patients[J].J Pediatr Hematol Oncol,2005,27:651.